Neocis Robotic Dental Implant Surgery Reaches 100,000 Osteotomies Milestone.
Technology continues to reshape healthcare, bringing greater precision, efficiency, and consistency to medical procedures. One area experiencing significant transformation is dental implant surgery, where robotics and artificial intelligence are helping clinicians enhance treatment planning and surgical execution.
Propel(x) listed company Neocis is contributing to this evolution through its Yomi® robotic platform. Designed specifically for dental implant procedures, Yomi combines robotic guidance with AI-powered planning tools to support clinicians throughout the surgical process.
Recently, Neocis announced a major milestone: more than 100,000 robotic osteotomies have been performed using the Yomi platform. The achievement reflects growing adoption of robotic-assisted dental implant technology and demonstrates increasing confidence among clinicians in robotics-supported workflows.
The Growing Role of Robotics in Dental Implant Surgery
Dental implant procedures have traditionally relied on a clinician’s experience, judgment, and manual precision. While these skills remain essential, advanced technologies can provide additional support during treatment planning and surgical execution.
The Yomi platform is designed to assist clinicians through AI-powered treatment planning and real-time robotic guidance. The system helps practitioners maintain precision while retaining full control over the procedure.
As dental practices increasingly adopt digital workflows, robotic-assisted technologies are becoming an important part of modern implant dentistry. The milestone of 100,000 robotic osteotomies highlights the expanding role of robotics in clinical settings.
Introducing the Next Generation of AI-Powered Planning
Neocis continues to build on its technology platform with innovations that further streamline clinical workflows.
One of the company’s latest developments is YomiPlan AI, a planning solution designed to automate key aspects of treatment preparation. The platform can identify critical anatomical structures and support treatment planning, helping clinicians save time while maintaining accuracy.
AI-assisted planning tools have the potential to improve workflow efficiency and provide clinicians with additional insights during case preparation. As healthcare organizations increasingly integrate artificial intelligence into clinical environments, solutions such as YomiPlan AI demonstrate how AI can support decision-making without replacing clinical expertise.
Industry Recognition for Innovation
In addition to its commercial milestones, Neocis recently received the 2026 TAG Award for MedTech in Robotic & Procedural Innovation.
The recognition highlights the company’s contributions to advancing healthcare technology and underscores the growing interest in robotic and AI-powered solutions across the medical sector.
Industry awards can serve as an indicator of innovation and market momentum, particularly in emerging technology categories where adoption continues to accelerate.
Looking Ahead
The combination of robotics, artificial intelligence, and digital treatment planning is helping shape the future of dental implant procedures. As adoption grows, technologies that support precision, workflow efficiency, and clinician decision-making are expected to play an increasingly important role in patient care.
With more than 100,000 robotic osteotomies completed, the introduction of YomiPlan AI, and recognition for innovation through the 2026 TAG Award, Neocis continues to demonstrate progress in the field of robotic-assisted dentistry.
Please note: Neocis is a company listed on the Propel(x) platform in 2017. No syndicate was formed. Propel(x) is not currently offering an investment opportunity in Neocis.
